SurVaxM is under clinical development by MimiVax and currently in Phase II for Glioblastoma Multiforme (GBM). According to GlobalData, Phase II drugs for Glioblastoma Multiforme (GBM) have a 23% phase ...
Skin eruptions include urticaria, erythema multiforme, eczema, and papulovesicular eruptions. These eruptions typically occur 5 to 8 days prior to menses and subside at the start of menarche.